Sclerosing mesenteritis: a systematic review of 192 cases
Autor: | Prabin Sharma, Christine Marie Needham, Paul Feuerstadt, Siddhartha Yadav |
---|---|
Rok vydání: | 2017 |
Předmět: |
medicine.medical_specialty
Low protein Lipodystrophy Ileus Retractile Mesenteritis Sclerosing mesenteritis Gastroenterology Panniculitis Peritoneal 03 medical and health sciences 0302 clinical medicine Terminology as Topic Internal medicine Humans Medicine Mesentery Obstructive uropathy business.industry General surgery General Medicine Prognosis medicine.disease Bowel obstruction Abdominal trauma 030220 oncology & carcinogenesis 030211 gastroenterology & hepatology business Abdominal surgery |
Zdroj: | Clinical Journal of Gastroenterology. 10:103-111 |
ISSN: | 1865-7265 1865-7257 |
DOI: | 10.1007/s12328-017-0716-5 |
Popis: | Sclerosing mesenteritis includes a spectrum of inflammatory disorders involving the adipose tissue of the bowel mesentery. To perform a systematic review of previously reported cases of sclerosing mesenteritis (SM) to determine the epidemiology, risk factors, methods of diagnosis, treatment patterns and outcomes for this disease. Medline, PubMed, Google Scholar and Cochrane database were searched using keywords mesenteric panniculitis, retractile mesenteritis, mesenteric lipodystrophy and sclerosing mesenteritis. Data was collated into a single excel database, transferred into SPSS (Version 21.0) and analyzed. Patients diagnosed with SM were between ages of 3 and 88 with a mean age of 55 ± 19.2 years. SM was more common in Caucasians (n = 28, 60.8% of those reporting ethnicity) and men (n = 133, 69.3%) with a male to female ratio of 2.3:1. 28.6% (n = 55) of patients reported a prior abdominal surgery or abdominal trauma, 8.9% (n = 17) had a history of malignancy, and 5.7% (n = 11) of autoimmune disease. 85.4% (n = 164) underwent surgical abdominal exploration (open or laparoscopic); 41.7% (n = 80) had surgery with resection of the involved bowel and mesentery. 34.9% (n = 67) of patients received medical treatment with the majority of them receiving steroids (n = 56, 83.5%). Symptom duration of more than a month (66.7% vs 40.4%, p |
Databáze: | OpenAIRE |
Externí odkaz: |